SEARCH

SEARCH BY CITATION

References

  • 1
    Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 2004; 9: 11371141.
  • 2
    Kanis JA, Delmas PD, Burckhardt P, Cooper C, Torgerson D. on behalf of the European Foundation for Osteoporosis and Bone Disease. Guidelines for diagnosis and management of osteoporosis. Osteoporos Int. 1997; 7: 390406.
  • 3
    Food and Drug Administration. Guidelines for Preclinical and Clinical Evaluation of Agents Used in the Prevention and Treatment of Postmenopausal Osteoporosis. Rockville, MD: Division of Metabolism and Endocrine Drug Products; 1994.
  • 4
    Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet. 2002; 359: 19291936.
  • 5
    Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performances of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007; 18: 10331046.
  • 6
    Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008; 19: 385397.
  • 7
    Kanis JA, McCloskey E, Johansson H, Strom O, Borgstrom F, Oden A. Case finding for the management of osteoporosis with FRAX: assessment and intervention thresholds for the UK. Osteoporos Int. 2008; 19: 13951408.
  • 8
    Trémollieres FA, Pouilles J-M, Laparra J, Ribot C. Bone mineral density at menopause does not predict breast cancer incidence. Osteoporos Int. 2008; 19: 14971504.
  • 9
    Ribot C, Pouilles JM, Bonneu M, Tremollieres F. Assessment of the risk of post-menopausal osteoporosis using clinical factors. Clin Endocrinol (Oxf). 1992; 36: 2258.
  • 10
    Pouillès JM, Trémollieres FA, Bonneu M, Ribot C. Influence of early age at menopause on vertebral bone mass. J Bone Miner Res. 1994; 9: 3115.
  • 11
    Trémollieres FA, Bauvin E, Cigagna A, et al. Association of cardiovascular risk factors with intima-media thickness of the carotid arteries in early postmenopausal women. Menopause. 2004; 11: 22330.
  • 12
    Fardellone P, Sebert JL, Bouraya M, et al. Evaluation de la teneur en calcium du régime alimentaire par autoquestionnaire fréquentiel. Rev Rhum. 1991; 58: 99103.
  • 13
    Pouillès JM, Trémollieres FA, Todorosvky N, Ribot C. Precision and sensitivity of dual-energy X-ray absorptiometry in spinal osteoporosis. J Bone Miner Res. 1991; 6: 9971001.
  • 14
    Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. Br Med J. 1996; 312: 12541259.
  • 15
    Huopio J, Kröger H, Honkanen R, Saarikoski S, Alhava E. Risk factors for perimenopausal fractures: a prospective study. Osteoporos Int. 2000; 11: 219227.
  • 16
    Abrahamsen B, Vestergaard P, Rud B, et al. Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish Osteoporosis Prevention Study. J Bone Miner Res. 2006; 21: 796800.
  • 17
    Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20: 11851194.
  • 18
    Klotzbuecher CM, Landsman PB, Abbott TA III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res. 2000; 15: 721739.
  • 19
    Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subsequent fracture risk. Bone. 2004; 35: 375382.
  • 20
    Hodsman AB, Leslie WD, Tsang JF, Gamble GD. 10-year probability of recurrent fracture following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba bone density program. Arch Intern Med. 2008; 168: 22612267.
  • 21
    Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on the risk of fracture and bone mineral density. The Women's Health Initiative randomized trial. JAMA. 2003; 290: 172938.
  • 22
    Fox KM, Magaziner J, Sherwin R, Scott JC, Plato CC, Nevitt M. Reproductive correlates of bone mass in elderly women. J Bone Miner Res. 1993; 8: 901908.
  • 23
    Nguyen TV, Jones G, Sambrook P, White CP, Kelly PJ, Eisman JA. Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. J Clin Endocrinol Metab. 1995; 80: 27092714.
  • 24
    Hillier TA, Rizzo JH, Pedula KL, et al. Nulliparity and fracture risk in older women: the Study of Osteoporotic Fracture. J Bone Miner Res. 2003; 18: 893899.
  • 25
    Kanis JA, Johansson H, Oden A, et al. A family history of fracture and fracture risk: a meta-analysis. Bone. 2004; 35: 10291037.
  • 26
    Kanis JA, Oden A, Johnell O, Jonsson B, de Laet C, Dawson A. The burden of osteoporotic fractures: A method for setting intervention thresholds. Osteoporos Int. 2001; 12: 417427.
  • 27
    Pluijm SMF, Koes B, De Laet C, et al. A simple risk score for the assessment of absolute fracture risk in general practice based on two longitudinal studies. J Bone Miner Res. 2009; 24: 768774.
  • 28
    Black DM, Steinbuch M, Palermo L, et al. An assessment tool for predicting fracture risk in postmenopausal women. Osteoporos Int. 2001; 12: 519528.
  • 29
    Chen Y-T, Miller PD, Barrett-Connor E, Weiss TW, Sajjan SG, Siris ES. An approach for identifying postmenopausal women age 50–64 years at increased short-term risk for osteoporotic fracture. Osteoporos int. 2007; 18: 12871296.
  • 30
    Sandhu SK, Nguyen ND, Center JR, Pocock NA, Eisman JA, Nguyen TV. Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporos Int. 2009; (in press).
  • 31
    Wald NJ, Hackshaw AK, Frost CD. When can a risk factor be used as a worthwhile screening test? BMJ. 1999; 319: 15621565.
  • 32
    Pepe MS, Janes H, Longton G, Leisenring W, Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am J epidemiol. 2004; 159: 882890.
  • 33
    Ware JH. The limitations of risk factors as prognostic tools. N Engl J Med. 2006; 355: 25.